Citadel Advisors »

Athira Pharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Athira Pharma shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $141k 34k 4.14

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Athira Pharma

Perceptive Advisors
BML Capital Management
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
Renaissance Technologies
Acadian Asset Management
Pathstone Holdings
BlackRock
Citadel Advisors
Geode Capital Management
Susquehanna International
Two Sigma Advisers
State Street Corporation

View all funds holding Athira Pharma